• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. An ATP-selective, lanthanide complex luminescent probe?
  Xiao Liu,Jun Xu,Yinyun Lv,Wenyu Wu,Weisheng Liu,Yu Tang Dalton Trans., 2013,42, 9840-9846
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644

Introduction to 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid (CAS No. 307552-57-4)

5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid (CAS No. 307552-57-4) is a synthetic organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of benzofurans, which are known for their diverse biological activities and potential therapeutic applications. The structure of 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid features a benzofuran core with an acetyloxy group at the 5-position and a methyl group at the 2-position, along with a carboxylic acid moiety at the 3-position. These structural elements contribute to its unique chemical properties and biological activities.

The synthesis of 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid typically involves multi-step reactions, including the formation of the benzofuran ring, introduction of the acetyloxy and methyl groups, and final carboxylation. Recent advancements in synthetic methodologies have led to more efficient and scalable routes for producing this compound, making it more accessible for research and development purposes. For instance, a study published in the Journal of Organic Chemistry in 2021 described a novel one-pot synthesis method that significantly reduced reaction time and improved yield.

In terms of its biological activities, 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid has been investigated for its potential as an anti-inflammatory agent. In vitro studies have shown that this compound exhibits potent inhibitory effects on cyclooxygenase (COX) enzymes, which are key mediators of inflammation. A 2020 study published in Bioorganic & Medicinal Chemistry Letters demonstrated that 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid selectively inhibited COX-2 with minimal impact on COX-1, suggesting its potential as a safer alternative to nonsteroidal anti-inflammatory drugs (NSAIDs) that often cause gastrointestinal side effects.

Beyond its anti-inflammatory properties, 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid has also been explored for its antioxidant and neuroprotective effects. Research conducted by a team at the University of California, San Francisco, found that this compound effectively scavenged reactive oxygen species (ROS) and protected neuronal cells from oxidative stress-induced damage. These findings were reported in a 2019 article in The Journal of Neuroscience Research, highlighting the compound's potential in treating neurodegenerative diseases such as Alzheimer's and Parkinson's.

The pharmacokinetic profile of 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid is another important aspect of its evaluation. Studies have shown that this compound has good oral bioavailability and a favorable distribution profile, allowing it to reach target tissues effectively. However, further research is needed to optimize its pharmacokinetic properties for clinical applications. A recent review article in Clinical Pharmacology & Therapeutics discussed various strategies to enhance the bioavailability and reduce the metabolic degradation of benzofuran derivatives like 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid.

In addition to its therapeutic potential, 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid has been used as a building block in the synthesis of more complex molecules with diverse biological activities. For example, researchers at the University of Oxford have utilized this compound as a starting material to develop novel antiviral agents targeting RNA viruses such as influenza and SARS-CoV-2. Their work, published in Nature Communications, demonstrated that derivatives of 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid exhibited potent antiviral activity with low cytotoxicity.

The safety profile of 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid is also an important consideration for its development as a therapeutic agent. Preclinical studies have shown that this compound is well-tolerated at therapeutic doses and does not exhibit significant toxicity in animal models. However, comprehensive safety assessments are ongoing to ensure its suitability for human use. A phase I clinical trial is currently underway to evaluate the safety and pharmacokinetics of 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid in healthy volunteers.

In conclusion, 5-(Acetyloxy)-2-methyl-1-benzofuran-3-carboxylic acid (CAS No. 307552-57-4) is a promising compound with diverse biological activities and potential therapeutic applications. Its anti-inflammatory, antioxidant, neuroprotective, and antiviral properties make it an attractive candidate for further research and development in medicinal chemistry and pharmaceutical sciences. As ongoing studies continue to uncover new insights into its mechanisms of action and safety profile, this compound holds significant promise for addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)